Europe Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Av

Europe Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)

The Europe poultry diagnostic market is expected to grow from US$ 54.50 million in 2022 to US$ 121.36 million by 2030. It is estimated to grow at a CAGR of 10.5% from 2022 to 2030.

Government Support and Initiatives Fuel Europe Poultry Diagnostic Market

In Europe, governments prioritize stringent regulatory frameworks to uphold the integrity and safety of the poultry industry. For instance, the European Union (EU) implements comprehensive regulations overseen by the European Commission’s Directorate-General for Health and Food Safety (DG SANTE). These regulations encompass strict biosecurity measures, disease prevention protocols, and hygiene standards aimed at safeguarding poultry health.

Countries within the EU, such as the Netherlands and France, have their own national regulatory bodies that work in alignment with EU standards. Additionally, the Netherlands Food and Consumer Product Safety Authority (NVWA) monitors and enforces stringent biosecurity measures and disease control protocols in poultry farms across the country. Similarly, France’s Ministry of Agriculture and Food ensures the implementation of robust regulations, focusing on disease prevention, vaccination programs, and strict monitoring of poultry health.

Additionally, the European Food Safety and Authority (EFSA) plays a crucial role in accessing and providing scientific advice on potential risks related to poultry health, contributing to the development and implementation of effective regulatory measures across the EU.

These stringent regulatory frameworks across Europe emphasize the commitment to ensuring high standards of poultry health, safety, and quality. They underscore the region’s dedication to upholding international standards, ensuring consumer confidence, and maintaining the competitiveness of the European poultry industry.

Europe Poultry Diagnostic Market Overview

The Europe poultry diagnostic market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The rising poultry diseases and government initiatives to overcome the situation are the major factors driving the market growth in Europe. The EU implemented extended control programs for zoonotic diseases, with Salmonella set as a priority. These programs include the provision of scientific advice and limitations on the trade of products from infected flocks. The Europe poultry diagnostic market in Germany is driven by increased R&D activities for the innovation of newer tests, a rise in the prevalence of infectious diseases such as bird flu in poultry, and the adoption of newer tests. Between November 2020 and May 2021, Germany faced the largest epidemic recorded of HPAI, with 245 outbreaks in poultry and captive birds and more than 1,000 diagnosed cases in wild birds. In March 2021, an HPAI outbreak of subtype H5N8 was confirmed in a holding rearing laying hens for sale. The H5N8 virus variant of HPAI in Germany was detected at a poultry farm in Lower Saxony in 2020. Thus, the abovementioned factors are expected to drive the Europe poultry diagnostic market in Germany during the forecast period.

Europe Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)

Europe Poultry Diagnostic Market Segmentation

The Europe poultry diagnostic market is segmented into test type, disease, and country.

Based on test type, the Europe poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the Europe poultry diagnostic market in 2022.

In terms of disease, the Europe poultry diagnostic market is segmented into Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, Newcastle Disease, Avian Mycoplasmosis, and Others. The Avian Influenza segment held the largest share of the Europe poultry diagnostic market in 2022.

By country, the Europe poultry diagnostic market is segmented into the Germany, Spain, France, UK, Italy, and the Rest of Europe. The Germany dominated the Europe poultry diagnostic market in 2022.

Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, IDVET, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and BioInGenTech Biotechnologies are some of the leading companies operating in the Europe poultry diagnostic market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe poultry diagnostic market.
Highlights key in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe poultry diagnostic market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.